
Incyte Corporation (Incyte) is a drug discovery and development company focused on developing small molecule drugs to treat serious unmet medical needs. The Company has a pipeline with programs in oncology, inflammation, diabetes and human immunodeficiency virus (HIV). Its pipeline... more

Sequenom, Inc. is a genetics and molecular diagnostic company providing genetic analysis products and services and developing diagnostic tests initially targeted at non-invasive prenatal genetic disorders. The Company's genetic analysis business provides applications that translate... more

Affymetrix, Inc. is engaged in the development, manufacture, sale and service of consumables and systems for genetic analysis in the life sciences and clinical healthcare markets. The markets for the Company’s products include all aspects of molecular biology research in the life... more

Ocimum Biosolutions is a leading integrated genomics company providing comprehensive Genomic Reference Databases, Life-Science Lab Information Management Solutions, GLP compliant Microarray Services and essential research consumables. Over 2/3rd of the top 25 Pharma companies, leading... more

Tm Bioscience Corporation is a DNA-based Diagnostics company developing a suite of genetic tests. Tm Bioscience's product pipeline includes tests for genetic mutations related to human disease, pharmacogenetics, and infectious disease. Tm Bioscience has advanced proprietary... more

Ciphergen is dedicated to the discovery of protein biomarkers and panels of biomarkers and their development into protein molecular diagnostic tests that improve patient care; and to providing collaborative R&D services through its Biomarker Discovery Center(R) laboratories for biomarker... more

MDS Proteomics is a drug discovery and development company transforming the detection and treatment of disease through proteomics. MDS Proteomics is working with Cephalon to apply proteomics to drug discovery and development across the value chain. MDS Proteomics and... more

MWG-Biotech is a leading international innovator of techniques, instruments, and services as a platform for success in life sciences today and for a better life tomorrow.

CombiMatrix Corporation, formerly Acacia Research-CombiMatrix, is a biotechnology company, with a subsidiary, CombiMatrix Molecular Diagnostics, Inc. (CMDX). CombiMatrix's electrochemical manufacturing process utilizes standard semiconductor technology, software and chemistry to build... more

Zyomyx Inc. is an innovator and leader in the development and commercialization of proprietary protein analysis platforms, with 8+ years of product development experience in protein biochips and biointerface technologies. With varied technology assets and a proven R&D core expertise in... more

Gentel Biosciences, Inc. is a protein microarray company whose mission is to deliver the most reliable tools, array kits and services for performing multiplex protein measurements to the life science community.

CapitaBio is a leading life science Company that develops and commercializes a broad range of products, including Biochip technology products, for drug discovery research, genomics, proteomics, bio-safety testing and clinical applications. Headquartered in Beijing, China, CapitalBio has... more

Based in San Diego, CA., AVIVA Biosciences Corporation develops enabling drug discovery and development technologies by combining biochips with cell biology. Key application areas include electrophysiology research, ion channel drug screening and rare-cell isolation. Founded in 1999 the... more

We are establishing an extensive set of research collaborations in order to understand the needs of our customers and deliver integrated solutions that maximize productivity. Genospectra has established a customer-based commercial organization. Our products are brought to market by sales... more

Microcide was founded in December 1992 to discover, develop and commercialize novel antibiotics for the treatment of serious bacterial infections. For over three years, Microcide has been applying its proprietary Targeted Genomics technology whereby it creates and uses bacterial and... more

Aviva Systems Biology also offers complete custom ChIP-DSL services. For more information or to discuss your experiments please contact us via email or phone at:email: chip-service@avivasysbio.comphone: 858-552-6979 or 888-880-0001 New Products ADAM30(ADAM metallopeptidase domain 30)... more

LumiCyte's www.lumicyte.com patented biochip and informatics products deliver new ways of unlocking the essence of human life. LumiCyte generates and distributes new knowledge through the acquisition, integration, and mining of genomics, proteomics, and clinical diagnostics information... more

Based in Dortmund, Germany, Protagen AG is counted among the worlds leading biotechnology companies. Established in 1997, Protagen AG constantly translates the latest technologies in proteomics, protein biochips, and bioinformatics into services and products from which the entire life... more

Ohmx is a dynamic and growing organization that seeks dedicated individuals committed to aggressive growth, scientific leadership and an entrepreneurial spirit. In return, Ohmx offers an exciting, challenging environment with great benefits and an attractive compensation package. If... more

DiagnoSwiss S.A. is a privately-held company committed to the development and commercialization of advanced biochips for the analysis of proteins in biological samples. DiagnoSwiss is developing an electrochemical biosensor platform based on proprietary microfluidic technologies for... more

"Protiveris Inc. is the world's leading technology company dedicated to the commercialization of micro- and nanocantilever systems for academic research, drug discovery and development, bio-defense and diagnostic applications."

TeleChem International, Inc., was founded in 1993 by Rene' Schena and Todd Martinsky as a chemical import and export trading company. TeleChem's Chemicals Division continues to expand and diversify, providing customers with the raw materials required for plastics, water soluble... more

SCIENION AG is a Berlin-based life science company offering complete solutions in the field of parallel bioanalytics. Customers include pharma and biotech companies as well as academic research institutions. Founded in December 2000 as a spin-off of the Max-Planck-Institute for Molecular... more

Mobious Biosystems was founded by Daniel Densham at the end of 1999, with venture funding. He conceived the technology underpinning molecular resonance sequencing ahead of his medical studies at Guy's, King's and St. Thomas's Medical and Dental School in London, UK. During his... more

GenoSensor Corporation is a genomic technology company, aiming to improve human healthcare by developing and marketing products and services for genomic research, drug discovery, predisposition gene screening, therapeutic assessment and other bioscience applications. GenoSensor's focus... more

GeneScan Europe AG is a Germany-based company engaged in the molecular biology sector. The Company is a provider of systems for the detection of genetically modified organisms (GMO) in seeds and agricultural commodities, as well as semi-finished and finished food products, through its... more

Aspira Biosystems is developing technology that enables the capture, with very high specificity, of targeted proteins. Aspira is actively seeking academic and commercial partners to develop therapeutic, medical research and industrial applications based on Partial Molecular Imprinting... more

Silicon Kinetics is a privately-held proteomics tools company headquartered in San Diego, California, with biochip labs in Maui, Hawaii. The Company specializes in instruments for optical interferometry in nano-porous silicon biochips. The SKi ProTM instrument platform and the SKi... more
![]() |
Add New Company | Add Your Profile | Tools & Resources | Developer API | Sales & Marketing Blog
FAQ | Privacy Policy | Terms of Service | About Us | Contact Us | Jobs at ZoomInfo
Copyright © 2009 Zoom Information Inc. All rights reserved.
BBeachHead-2009-12-03_RC001.1 OM17